The Government has agreed a deal that will see the United Kingdom purchase up to 60 million doses of a potential vaccine being developed by Sanofi and GlaxoSmithKline to prevent Coronavirus.

It is hoped that if trials are successful, that the vaccine could be rolled out to vulnerable members of the public by early next year.